You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?

Article metrics

Article menu

Download PDFPDF

Review
Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?

 

Online download statistics by month:

Online download statistics by month: August 2023 to September 2025

AbstractFullPdf
Aug 2023570577207
Sep 202322322657
Oct 202313515160
Nov 202320020848
Dec 202317217473
Jan 2024575928
Feb 2024686925
Mar 202411211451
Apr 202411011040
May 202426726942
Jun 2024656732
Jul 202410410743
Aug 2024706923
Sep 202410410239
Oct 2024878738
Nov 2024919330
Dec 202413213430
Jan 2025939438
Feb 202525225236
Mar 2025979739
Apr 202510110136
May 2025888856
Jun 2025515123
Jul 2025110
Aug 2025110
Sep 2025550
Total325633061094